Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stephan Dirnhofer

Showing results (21-30 of 155) with videos related to

Pageof 16
Sort By:
The Journal of Histochemistry and Cytochemistry : Official Journal of the Histochemistry Society|February 19, 2002
Human lipocalin-1, a physiological scavenger of lipophilic compounds, is produced by corticotrophs of the pituitary glandPetra Wojnar, Stephan Dirnhofer, Peter Ladurner, et al.
Applied Immunohistochemistry & Molecular Morphology : AIMM|October 8, 2008
Diagnostic utility of the B-cell lineage markers CD20, CD79a, PAX5, and CD19 in paraffin-embedded tissues from lymphoid neoplasmsHeiner Adams, Peter Liebisch, Patrik Schmid, et al.
Expert Opinion on Therapeutic Targets|November 25, 2010
PCM1-JAK2-fusion: a potential treatment target in myelodysplastic-myeloproliferative and other hemato-lymphoid neoplasmsSylvia Hoeller, Christoph Walz, Andreas Reiter, et al.
Pathobiology : Journal of Immunopathology, Molecular and Cellular Biology|November 3, 2016
Lymphadenectomy Specimens in a Large Retrospective Cohort of Pediatric Patients Reveal No in situ Lymphomas but a Broad Spectrum of Reactive ChangesYara Banz, Alexandar Tzankov, Stephan Dirnhofer, et al.
Histopathology|June 29, 2010
FOXP1 protein overexpression is associated with inferior outcome in nodal diffuse large B-cell lymphomas with non-germinal centre phenotype, independent of gains and structural aberrations at 3p14.1Sylvia Hoeller, Aurelia Schneider, Eugenia Haralambieva, et al.
Expert Opinion on Therapeutic Targets|August 27, 2009
Clinical, phenotypic and genetic similarities and disparities between post-transplant and classical Hodgkin lymphomas with respect to therapeutic targetsHeiner Adams, Cristina Campidelli, Stephan Dirnhofer, et al.
Cancer Journal (Sudbury, Mass.)|February 7, 2009
Distant metastatic breast cancer as an incurable disease: a tenet with a need for revisionUwe Güth, Dorothy Jane Huang, Stephan Dirnhofer, et al.
Human Pathology|November 17, 2009
Epstein-Barr virus-positive diffuse large B-cell lymphoma in elderly patients is rare in Western populationsSylvia Hoeller, Alexandar Tzankov, Stefano A Pileri, et al.
Human Pathology|June 11, 2005
Placental site trophoblastic tumor of the mediastinumPhilip Th Went, Stephan Dirnhofer, Thoman Stallmach, et al.
Expert Opinion on Therapeutic Targets|April 27, 2010
Class I histone deacetylases 1, 2 and 3 are highly expressed in classical Hodgkin's lymphomaHeiner Adams, Florian R Fritzsche, Stephan Dirnhofer, et al.
Pageof 16

Showing results (21-30 of 155) with videos related to

Sort By:
Pageof 16
The Journal of Histochemistry and Cytochemistry : Official Journal of the Histochemistry Society|February 19, 2002
Human lipocalin-1, a physiological scavenger of lipophilic compounds, is produced by corticotrophs of the pituitary glandPetra Wojnar, Stephan Dirnhofer, Peter Ladurner, et al.
Applied Immunohistochemistry & Molecular Morphology : AIMM|October 8, 2008
Diagnostic utility of the B-cell lineage markers CD20, CD79a, PAX5, and CD19 in paraffin-embedded tissues from lymphoid neoplasmsHeiner Adams, Peter Liebisch, Patrik Schmid, et al.
Expert Opinion on Therapeutic Targets|November 25, 2010
PCM1-JAK2-fusion: a potential treatment target in myelodysplastic-myeloproliferative and other hemato-lymphoid neoplasmsSylvia Hoeller, Christoph Walz, Andreas Reiter, et al.
Pathobiology : Journal of Immunopathology, Molecular and Cellular Biology|November 3, 2016
Lymphadenectomy Specimens in a Large Retrospective Cohort of Pediatric Patients Reveal No in situ Lymphomas but a Broad Spectrum of Reactive ChangesYara Banz, Alexandar Tzankov, Stephan Dirnhofer, et al.
Histopathology|June 29, 2010
FOXP1 protein overexpression is associated with inferior outcome in nodal diffuse large B-cell lymphomas with non-germinal centre phenotype, independent of gains and structural aberrations at 3p14.1Sylvia Hoeller, Aurelia Schneider, Eugenia Haralambieva, et al.
Expert Opinion on Therapeutic Targets|August 27, 2009
Clinical, phenotypic and genetic similarities and disparities between post-transplant and classical Hodgkin lymphomas with respect to therapeutic targetsHeiner Adams, Cristina Campidelli, Stephan Dirnhofer, et al.
Cancer Journal (Sudbury, Mass.)|February 7, 2009
Distant metastatic breast cancer as an incurable disease: a tenet with a need for revisionUwe Güth, Dorothy Jane Huang, Stephan Dirnhofer, et al.
Human Pathology|November 17, 2009
Epstein-Barr virus-positive diffuse large B-cell lymphoma in elderly patients is rare in Western populationsSylvia Hoeller, Alexandar Tzankov, Stefano A Pileri, et al.
Human Pathology|June 11, 2005
Placental site trophoblastic tumor of the mediastinumPhilip Th Went, Stephan Dirnhofer, Thoman Stallmach, et al.
Expert Opinion on Therapeutic Targets|April 27, 2010
Class I histone deacetylases 1, 2 and 3 are highly expressed in classical Hodgkin's lymphomaHeiner Adams, Florian R Fritzsche, Stephan Dirnhofer, et al.
Pageof 16